Advanced SearchSearch Tips
Screening and Characterization of Lactobacillus casei MCL Strain Exhibiting Immunomodulation Activity
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Screening and Characterization of Lactobacillus casei MCL Strain Exhibiting Immunomodulation Activity
Choi, Jae-Kyoung; Lim, Yea-Seul; Kim, Hee-Jin; Hong, Yeong-Ho; Ryu, Buom-Yong; Kim, Geun-Bae;
  PDF(new window)
As an appraisal for the application of a new starter culture, more than 200 lactic acid bacteria strains were isolated from raw milk and healthy human feces. The strains showing excellent growth and acid production ability in 10% skim milk media were selected and identified as Lactobacillus casei based on the results of their API carbohydrate fermentation patterns, as well as 16S rDNA sequence analysis. To assess the effect of L. casei strains on irritable bowel disease (IBD), the inhibitory effect of the selected strains against the nitric oxide (NO) production of lipopolysaccharide (LPS)-stimulated RAW 264.7 cells was measured. Among the tested L. casei strains, L. casei MCL was observed to have the greatest NO inhibitory activity. Additionally, L. casei MCL was found to inhibit mRNA expression of pro-inflammatory cytokines (interleukin-, IL-6, TNF-), as well as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) involved in pathophysiologic processes such as inflammation. The mRNA expression of anti-inflammatory cytokines, including IL-10 and transforming growth factor- (TGF-) of L. casei MCL, was confirmed using quantitative real-time PCR. In conclusion, L. casei MCL showed decreases in the expression of pro-inflammatory cytokines and up-regulated expression of the anti-inflammatory cytokine.
immunomodulating;Lactobacillus casei;probiotics;cytokine;
 Cited by
Screening and Characterization of Lactic Acid Bacteria Strains with Anti-inflammatory Activities through in vitro and Caenorhabditis elegans Model Testing, Korean Journal for Food Science of Animal Resources, 2015, 35, 1, 91  crossref(new windwow)
Cirino, G., Distrutti, E., and Wallace, J. L. (2006) Nitric oxide and inflammation. Inflamm. Allergy Drug Target 5, 115-119. crossref(new window)

Coleman, J. W. (2001) Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1, 1397-1406. crossref(new window)

de Waard, R., Garssen, J., Snel, J., Bokken G. C., Sako, T., Veld, J. H., and Vos, J. G. (2001) Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT 9029 in Wister and Brown Norway rats. Clin. Diagn. Lab. Immun. 8, 762-767.

Food and Agriculture Organization of the United Nations. (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. (

Fuller, R. (1993) Probiotic foods, current use and future developments. Int. Food Ingred. 3, 23-26.

Gilliland, S. E. and Walker, D. K. (1990) Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J. Dairy Sci. 73, 905-911. crossref(new window)

Hanauer, S. B. (2002) New steroids for IBD: progress report. Gut 51, 182-183. crossref(new window)

Henderson, B., Poole, S., and Wilson, M. (1996) Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60, 316-341.

Ishikawa, H., Akedo, I., Otani, T., Suzuki, T., Nakamura, T., Takeyama, I., Ishiquro, S., Miyaoka, E., Sobue, T., and Kakizoe, T. (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116, 762-767. crossref(new window)

Jeong, I. Y., Lee, H. J., Jin, C. H., Park, Y. D., Choi, D. S., and Kang, M. A. (2010) Anti-inflammatory activity of Stevia rebaudiana in LPS-induced RAW 264.7 cells. J. Food Sci. Nutr. 15, 14-18. crossref(new window)

Kakizoe, T. (2000) Asian studies of cancer chemoprevention: latest clinical results. Eur. J. Cancer 36, 1303-1309 crossref(new window)

Kandler, O. and Weiss, N. (1986) Genus Lactobacillus Beijerinck 1901. In: Bergey's manual of systematic bacteriology, Vol. 2. Sneath, P. H. A., Mair, N. S., Sharpe, M. E., and Holt, J.G. (eds) Williams and Wilkins, Baltimore, pp. 1209-1234.

Kato, I., Yokokura, T., and Mutai, M. (1984) Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiol. Immunol. 27, 209-217.

Lane, D. J. (1991) 16S/23S rRNA sequencing. In: Nucleic acid techniques in bacterial systematics. Stackebrandt, E. & Goodfellow, M. (eds) John Wiley, Chichester, pp. 115-175.

Lee, J. H., Lee, B., Lee, H. S., Bae, E. A., Lee, H., Ahn, Y. T., Lim, K. S., Huh, C. S., and Kim, D. H. (2009) Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-$\kappa B$ activation in experimental colitis. Int. J. Colorectal Dis. 24, 231-237. crossref(new window)

Lee, H. S., Han, S. Y., Bae, E. A., Huh, C. S., Ahn, Y. T., Lee, J. H., and Kim, D. H. (2008) Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodiuminduced colitic mice. Int. Immunopharmacol. 8, 574-580. crossref(new window)

Macdonald, T. T. and Monteleone, G. (2005) Immunity, inflammation, and allergy in the gut. Science 307, 1920-1925. crossref(new window)

Majamaa, H. and Isolauri, E. (1997) Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99, 175-185.

Matsubuchi, T., Takagi, A., Matsuzaki, T., Nagaoka, M., Ishikawa, K., Yokokura, T., and Yoshikai, Y. (2003) Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immun. 10, 259-266.

Matsumoto, S., Hara, T., Hori, T., Mitsuyama, K., Nagaoka, M., Tomlyasu, N., Suzuki, A., and Sata, M. (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 140, 417-426. crossref(new window)

Menard, S., Candalh, C., Bambou, J. C., Terpend, K., Cerf- Bensussan, N., and Heyman, M. (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53, 821-828. crossref(new window)

Morotomi, M. (1996) Properties of Lactobacillus casei Shirota strain as probiotics. Asia Pacific J. Clin. Nutr. 5, 29-30.

Narvhus, J. (1996) Probiotiske bakterier-metabolisme in melk. Meieriposten 12, 341-343.

Nathan, C. and Xie, Q. W. (1994) Nitric oxide synthases: roles, tolls and controls. Cell 78, 915-918. crossref(new window)

Pena, J. A. and Versalovic, J. (2003) Lactobacillus rhamnosus GG decreases TNF-$\alpha$ production in lipopolysaccharideactived murine macrophages by a contact-independent mechanism. Cell Microbiol. 5, 277-285. crossref(new window)

Sadowsky, D. W., Novy, M. J., Witkin, S. S., and Gravett, M. G. (2003) Dexamethasone or interleukin-10 blocks interleukin- 1 beta-induced uterine contractions in pregnant rhesus monkeys. Am. J. Obstet. Gynecol. 188, 252-236. crossref(new window)

Sambrook, J., Fritsch, E. F., and Maniates, T. (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.

Samona, A. and Robinson. R. K. (1991) Enumeration of bifidobacteria in dairy products. J. Soc. Dairy Technol. 44, 64-66. crossref(new window)

Sanders, M. E. (1993) Effect of consumption of lactic cultures on human health. In: Advance in Food and Nutrition Research. Kinsella, J. (ed) Academic Press, San Diego, pp. 67-130.

Stein, B. and Sutherland, M. S. K. (1998) IL-6 as a drug discovery target. Drug Discov. Today 3, 202-213. crossref(new window)

Stuehr, D. J. and Marlette, M. A. (1985) Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Nat'l. Acad. Sci. USA 82, 7738-7742. crossref(new window)

Stuehr, D. J. and Marlette, M. A. (1987) Induction of nitrite/ nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-$\gamma$. J. Immunol. 39, 518-525.

Trushin, S. A., Pennington, K. N., Carmona, E. M., Asin, S., Savoy, D. N., Billadeau, D. D., and Paya, C. V. (2003) Protein kinase $C \alpha$ ($PKC \alpha$) acts upstream of PK theta to activate I$\kappa B$ kinase and NF-$\kappa B$ in T lymphocytes. Mol. Cell Biol. 23, 7068-7081. crossref(new window)

Ulevitch, R. J. and Tobias. P. S. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Ann. Rev. Immunol. 13, 437-457. crossref(new window)

Wai, P. Y. and Kuo, P. C. (2004) Nitric oxide and endotoxinmediated sepsis: the role of osteopontin. Gene Ther. Mol. Biol. 8, 501-508.

Yeganegi, M., Leung, C. G., Martins, A., Kim, S. O., Reid, G., Challis, J. R. G., and Bocking, A. D. (2010) Lactobacillus rhamnosus GR-1-induced IL-10 production in human placental trophoblast cells involves activation of JAK/STAT and MAPK pathways. Reprod. Sci. 17, 1043-1051. crossref(new window)